We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$1.28B
AUM Growth
+$182M
Cap. Flow
+$104M
Cap. Flow %
8.16%
Top 10 Hldgs %
33.36%
Holding
496
New
51
Increased
276
Reduced
103
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.32M
2
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$4.36M
3
AVGO icon
Broadcom
AVGO
+$3.59M
4
ORCL icon
Oracle
ORCL
+$3.13M
5
MSFT icon
Microsoft
MSFT
+$2.98M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.39M
2
FICO icon
Fair Isaac
FICO
+$859K
3
EOG icon
EOG Resources
EOG
+$838K
4
FAST icon
Fastenal
FAST
+$837K
5
CL icon
Colgate-Palmolive
CL
+$760K

Sector Composition

Rank Sector Weight
1 Technology 21.88%
2 Financials 9.45%
3 Communication Services 6.51%
4 Consumer Discretionary 5.5%
5 Industrials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
76
Merck
MRK
$318B
$3.36M 0.26%
40,089
+3,804
+10% +$313K
WFC icon
77
Wells Fargo
WFC
$264B
$3.35M 0.26%
39,938
+7,657
+24% +$621K
VB icon
78
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$3.34M 0.26%
13,133
+631
+5% +$156K
UNH icon
79
UnitedHealth
UNH
$370B
$3.33M 0.26%
9,646
+1,006
+12% +$304K
IBM icon
80
IBM
IBM
$224B
$3.17M 0.25%
11,229
+2,388
+27% +$625K
AMD icon
81
Advanced Micro Devices
AMD
$789B
$3.12M 0.24%
19,259
+246
+1% +$39.7K
GEV icon
82
GE Vernova
GEV
$264B
$3.1M 0.24%
5,043
+2,670
+113% +$1.62M
COF icon
83
Capital One
COF
$134B
$3.02M 0.24%
14,193
+332
+2% +$72.7K
CRM icon
84
Salesforce
CRM
$158B
$2.96M 0.23%
12,503
+621
+5% +$157K
IEMG icon
85
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$2.88M 0.22%
43,673
+2,875
+7% +$179K
MCK icon
86
McKesson
MCK
$101B
$2.88M 0.22%
3,723
+75
+2% +$52.8K
MDYV icon
87
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.83B
$2.76M 0.22%
33,117
MU icon
88
Micron Technology
MU
$991B
$2.76M 0.22%
16,484
+104
+0.6% +$13.3K
DIA icon
89
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
$2.71M 0.21%
5,849
TMO icon
90
Thermo Fisher Scientific
TMO
$220B
$2.68M 0.21%
5,522
+1,448
+36% +$674K
APP icon
91
Applovin
APP
$116B
$2.53M 0.2%
3,515
+2,314
+193% +$1.07M
DUHP icon
92
Dimensional US High Profitability ETF
DUHP
$12.7B
$2.5M 0.2%
66,294
HON icon
93
Honeywell
HON
$78B
$2.48M 0.19%
12,520
+1,505
+14% +$314K
VOT icon
94
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
$2.46M 0.19%
8,389
VIG icon
95
Vanguard Dividend Appreciation ETF
VIG
$114B
$2.4M 0.19%
11,111
ADP icon
96
Automatic Data Processing
ADP
$108B
$2.35M 0.18%
8,013
+160
+2% +$48.2K
PEP icon
97
PepsiCo
PEP
$190B
$2.3M 0.18%
16,357
+2,214
+16% +$316K
LNG icon
98
Cheniere Energy
LNG
$52.9B
$2.27M 0.18%
9,669
+889
+10% +$209K
BRK.A icon
99
Berkshire Hathaway Class A
BRK.A
$1.12T
$2.26M 0.18%
3
MCD icon
100
McDonald's
MCD
$195B
$2.23M 0.17%
7,330
+93
+1% +$28.3K

Similar funds

Fidelis Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Fidelis Capital Partners held 496 positions worth $1.28B, up 17% from $1.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Fidelis Capital Partners deployed $104M of net new capital in Q3 2025, opening 51 new positions and adding to 276 existing holdings. Its largest new stake was Avantis Emerging Markets Equity ETF: 61,049 shares worth $4.59M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $1.39M trimmed.

  • Fidelis Capital Partners's largest Q3 2025 buy was Avantis Emerging Markets Equity ETF: 61,049 shares worth $4.59M.
  • Fidelis Capital Partners added most to NVIDIA in Q3 2025, an estimated $6.32M increase.
  • Fidelis Capital Partners's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $1.39M.
  • Fidelis Capital Partners fully exited SLB Ltd in Q3 2025, selling an estimated $453K.
  • Fidelis Capital Partners's ten largest holdings make up 33% of its $1.28B portfolio in Q3 2025.
  • Fidelis Capital Partners opened 51 new positions and closed 7 in Q3 2025.
  • Fidelis Capital Partners's portfolio value rose 17% quarter-over-quarter to $1.28B.

Based on Fidelis Capital Partners's 13F filing for Q3 2025, filed 3 Nov 2025.